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doi:10.1016/j.ejvs.2008.12.001Abstract Background: It has been shown that concomitant percutaneous transluminal angio-
plasty (PTA) of above-the-knee (ATK) and below-the-knee (BTK) arteries is highly beneficial for
limb salvage in patients with critical limb ischaemia (CLI), but few published studies have
specifically investigated outcomes in diabetic patients with CLI associated with isolated small
BTK-vessel disease. This study aimed to evaluate the long-term results of successful PTA for
limb salvage in such patients.
Materials and methods: From among the 634 patients with CLI in our database, we retrospec-
tively selected a consecutive series of 101 diabetics (16%) with 107 critically ischaemic limbs
(33 Rutherford 5 and 74 Rutherford 6) and no critical ATK lesion, who underwent PTA on iso-
lated BTK lesions.
Results: The limb salvage rate was 93% after a mean follow-up of 1048 525 days (2.9 1.4
years). Transcutaneous oxygen tension significantly increased after 1 month (18.1 11.2 vs.
39.6  15.1; p< 0.05). After 1 year, target-vessel re-stenosis had occurred in 42% of the
non-amputated limbs, nine patients (9%) had died because of medical conditions unrelated
to PTA and three patients had undergone repeat PTA for recurrent CLI.
Conclusions: In our selected patient population with ischaemic diabetic foot and isolated BTK
lesions, a successful endovascular procedure led to a high percentage of limb salvage at long-
term follow-up.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.02 55033532; fax: þ39 02
B. Danzi).
ty for Vascular Surgery. PublishePeripheral percutaneous transluminal angioplasty (PTA) is
a feasible method of treating critical limb ischaemia (CLI)
whose outcomes are similar to those of bypass surgery.1,2
However, studies of PTA in CLI have involved veryd by Elsevier Ltd. All rights reserved.
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knowledge of the value of PTA in particular patient subsets.
Many of the published studies included diabetic and
non-diabetic patients, different stages of ischaemia
(claudication, resting pain or tissue lesions) and PTA of
above-the-knee (ATK) and below-the-knee (BTK) vessels
performed in the same setting.3e9 Furthermore, in many
studies of BTK PTA, the most frequently treated vessels
were the distal popliteal artery and the tibioperoneal
trunk, whose diameters are more similar to those of ATK
arteries than those of the smaller BTK arteries.5e10
It is well known that atherosclerotic involvement in
diabetic patients with CLI mainly affects BTK arteries (leg
and foot vessels),11 but the therapeutic efficacy of PTA in
such patients has not been clearly defined, especially given
the high incidence of re-stenosis.12 This study aimed to
evaluate the long-term clinical outcomes and re-stenosis
rate of PTA procedures performed for the purpose of limb
salvage.Methods
Study design
In the year 2000, we initiated a prospectively maintained
database in which to record the clinical data of all of the
patients treated in our catheterisation laboratory. We have
now retrospectively reviewed this database in order to
identify the patients with CLI (as defined by TASC II criteria)
treated with PTA between March 2000 and December 2005
who satisfied the following parameters: (1) a history of
diabetes mellitus diagnosed on the basis of the American
Diabetes Association criteria13; (2) an ischaemic foot lesion
(Fontaine stage 4; Rutherford category 5 and 6); (3) the
absence of any critical lesion (>70% diameter stenosis or
occlusion in the ATK arteries, the distal popliteal artery and
the tibioperoneal trunk and (4) the presence of criticalFigure 1 Study design: patient selection. CLI: critical limb i
percutaneous transluminal angioplasty and pts: patients.small-BTK artery lesions, defined as >70% stenosis or
occlusion involving either three leg vessels (anterior tibial,
posterior tibial and peroneal arteries), with or without
foot-vessel involvement (pedal or plantar arteries), or one
or two leg vessels and at least one foot vessel (Figs. 1
and 2).
Treatment protocol
All of the patients were treated in a specialised diabetic-
foot clinic and underwent a three-step treatment
protocol:
1. Pre-PTA: Surgical treatment to remove necrotic tissue
and drain the abscess and phlegmon; broad-spectrum
antibiotic therapy (piperacillinþ tazobactam and
metronidazole) until a more specific indication emerged
from the microbiological specimens; glycaemic control;
and double antiplatelet therapy with aspirin (100 mg per
day) and clopidogrel (a 300-mg loading dose followed by
75 mgper day). A nephro-protection protocolwas used in
all patients with creatinine levels of >1.1 mg dl1:
a 1.0 ml kg1 h1 saline infusion (0.5 ml kg1 h1 in
patients with a history of heart failure) 12 h before and
24 h after the procedure and oral N-acetyl-cysteine
1200 mg twice daily on the day before and the day of the
procedure.
2. Angiography and PTA: The procedures were performed
under local anaesthesia by two operators at the same
time. An anterograde puncture of the ipsilateral,
common femoral artery was systematically used, even
in obese patients, as was a 4/F introducer sheath.
Optimal imaging of the vessel tree was obtained by
using the non-ionic contrast medium iodixanol (Visipa-
que 320, GE Healthcare, USA), digital subtraction
angiography, multiple oblique views and a lateral foot
projection. A 0.01400 wire (PT2, Boston Scientific, USA)
was used to cross the lesions. Total occlusions wereschaemia, ATK: above-the-knee; BTK: below-the-knee; PTA:
Figure 2 A successful endovascular procedure, defined as
the restoration of straight-line flow down to the foot circle in
at least one crural artery with no significant residual stenosis
(>30%). Outcome: salvaged limb.
338 R. Ferraresi et al.preferably re-canalised through the true arterial lumen
using dedicated 0.01400 coronary wires such as Con-
fianza (Asahi, Japan), but a sub-intimal approach14 was
used in some cases after the failure of the endoluminal
approach. Small profile balloons (Bijou, Boston Scien-
tific, USA; Submarine Plus and Amphirion Deep, Inva-
tec, Italy) were inflated to 12e15 atm for 2 min. The
balloon dimensions were chosen on the basis of the size
of the artery and the length of the lesion. Stenting was
only used in the case of a flow-limiting dissection that
was not resolved by prolonged (5e10-min) balloon
inflations. At the beginning of the PTA procedure, 5
000 IU of heparin were routinely administered intra-
arterially, and additional heparin was given, if needed,
to maintain an activated clotting time (ACT) of about
250 s. If vessel spasm occurred, 0.1e0.2 mg of nitro-
glycerine was infused as an intra-arterial bolus. At the
end of the procedure, haemostasis was obtained by
means of local compression.
3. Post-PTA treatment: Elective surgery was performed
within 1 week with the aim of reconstructing a stumpsuitable for proper walking. All of the patients received
double antiplatelet therapy for a minimum of 1 month
(aspirin 100 mg and clopidogrel 75 mg per day); the
treatment was not interrupted when surgical proce-
dures were undertaken. No patient received prostanoid
therapy or underwent lumbar sympathectomy. After
discharge, the patients were seen in our out-patient
clinic every week for the first month, monthly for the
next 5 months and then every 3 months. All of the
patients received optimal medical treatment for
vascular risk factors.Transcutaneous oxygen tension measurements
Transcutaneous partial oxygen tension (TcPO2) was
measured at baseline (T0), the day after the procedure (T1)
and 1 month later (T2). All of the measurements were made
at the dorsum of the foot, in the peri-lesional site, using
a TCM 3 Radiometer (GMBH, Copenhagen, Denmark).
Colour duplex ultrasound
The patients who had not undergone a major amputation
after 1 year were examined by a single operator using
colour duplex ultrasonography (US). Peak systolic velocity
(PSV) in the target-vessel was determined and compared
with that in the preceding normal segment. A focal increase
of at least 140% in the PSV (corresponding to a peak velocity
ratio of >2.4) was considered indicative of >50% re-stenosis
at that site.15,16
End-points and definitions
The procedure was considered successful when it was
possible to restore straight-line flow down to the foot circle
in at least one crural artery with no significant residual
stenosis (>30%).
In the case of isolated PTA of the peroneal artery,
a successful procedure was defined as good distal collat-
eralisation to the foot circle.
The primary end-point of the study was the rate of limb
salvage at follow-up, defined as an ability to maintain
plantar standing even if it required a minor (below-the-
ankle) amputation.
The secondary end-points were: (1) the 1-month
improvement in TcPO2 from baseline; (2) the occurrence of
all-cause death during the follow-up period; (3) the rate of
US re-stenosis of the treated vessels after 1 year and (4) the
incidence of new re-vascularisation interventions involving
the same limb.
Statistical analysis
The continuous data are given as mean values standard
deviation. The TcPO2 was compared between two groups
(T0 vs. T1, T0 vs. T2 and T1 vs. T2) using the Student’s
t-test. A p-value of <0.05 was considered statistically
significant. The rate of survival and limb salvage for
successful and unsuccessful PTA has been estimated by the
KaplaneMeier approach with 95% confidence intervals.
Table 2 Baseline angiographic patterns
Diseased vessels
in 107 limbs
No. %
Anterior tibial 103 96
Posterior tibial 104 97
Peroneal 74 69
Pedal artery 51 48
Plantar artery 74 69
0 leg vessel e e
1 leg vessel 4 4
2 leg vessels 32 30
3 leg vessels 71 66
0 foot vessel 28 26
1 foot vessel 33 31
2 foot vessels 46 43
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Population
Of the 634 patients with CLI in our database, 101 (16%) with
107 critically ischaemic limbs (33 Rutherford 5 and 74
Rutherford 6) met the selection criteria and were included
in the study. The mean duration of diabetes mellitus was
15.3 4.7 years, and 55% of the patients were receiving
insulin. Mean glycated haemoglobin (HbA1c) was
7.6% 1.8%. Fifty-one patients (50%) had arterial hyper-
tension, and 28 (38%) a history of coronary artery disease.
Table 1 summarises the patients’ characteristics.
Baseline angiographic patterns
Critical lesions were found in 406 BTK vessels: 103 anterior
tibial, 104 posterior tibial, 74 peroneal, 51 pedal and 74
plantar arteries. The distribution of the diseased vessels is
shown in Table 2.
Angioplasty procedure
PTA was considered successful in 94 patients (100 limbs).
The angiographic characteristics of the successfully treated
vessels are shown in Table 3. The mean length of treated
vessel per limb was 21.3 15.2 cm. Only four stents were
implanted because of occlusive dissection.
The procedure was unsuccessful in seven patients (seven
limbs), in whom all of the three leg vessels were totally
occluded: the reasons for the failures were an inability to
cross a highly calcified chronic total occlusion and/or an
inability to dilate the lesions properly with the balloon.
These patients were not suitable for surgical re-
vascularisation.
There were two minor complications (two groin hae-
matomas that did not require any special treatment), and
therefore the overall complication rate was 1.9%.
Primary end-point
The mean follow-up was 1048 525 days (2.9 1.4 years);
none of the patients was lost to follow-up. The majorTable 1 Demographic data of the 101 study patients
Variables
Age (years) 65.9 9.4
Females (No.) 16 16%
BMI 26.65 4.01
Obese patients (BMI> 30) 18 18%
Insulin therapy (No.) 53 53%
Duration of diabetes (years) 15.3 4.7
HbA1c (%) 7.6 1.8
Dialysis (No.) 3 3%
Hypertension (No.) 51 50%
Coronary disease (No.) 28 28%
History of stroke (No.) 4 4%amputation rate was 7% (eight out of 107 limbs: two of the
thigh and six of the leg); the limb salvage rate was 93% (99
out of 107 limbs). The minor amputation rate was 64% (69
out of 107 limbs: four Lisfranc, 17 Chopart, 16 trans-
metatarsal, 21 rays and 11 toes). The major amputation
rate was significantly lower in the patients who underwent
a successful procedure than in those in whom the proce-
dure was unsuccessful (5% vs. 43%; pZ 0.003). Fig. 3 shows
the KaplaneMeier curves (and 95% confidence bands) of
limb salvage for successful and unsuccessful PTA.
Secondary end-points
Baseline TcPO2 was 18.1 11.2 mmHg, which increased to
39.6 15.1 mmHg on the day after the procedure
(p< 0.001) and to 58.2 13.9 mmHg after 1 month
(p< 0.001 vs. baseline; p< 0.05 vs. post-procedural
values).
During the follow-up period, nine patients died (9%)
because of medical conditions unrelated to PTA: cardiac
disease (six), stroke (two) and malignancy (one). Mortality
was significantly lower in the successful PTA group (five out
of 94 patients, 5%) than in the unsuccessful PTA group (four
out of seven patients, 57%) (p< 0.001). Fig. 4 shows theTable 3 Characteristics of successfully treated vessels
Artery No. (%) Stenosis
(n)
Mean
length
 SD
(mm)
Occlusions
(n)
Mean
length
 SD
(mm)
Anterior
tibial
57 (36) 30 115 112 27 228 98
Posterior
tibial
35 (22) 17 112 105 18 192 101
Peroneal 44 (28) 32 108 81 12 156 92
Pedal
artery
15 (9.5) 6 50 23 1 50
Plantar
artery
7 (4.4) 15 48 21 0 0
Total 158 (100) 100 98 91 58 199 101
Figure 3 KaplaneMeier curves (and 95% confidence bands) of
limb salvage for successful (group 1, solid line) and unsuc-
cessful (group 2, dashed line) PTA.
340 R. Ferraresi et al.KaplaneMeier survival curves (and 95% confidence bands)
for successful and unsuccessful PTA.
The 1-year target-vessel re-stenosis rate was 42% (66 out
of 158 lesions): 35% (35 out of 100) in stenotic lesions and
53% (31 out of 58) in occlusive lesions.
Three patients underwent a second successful PTA
procedure because of recurrent CLI in the same limb.
Discussion
The main finding of our study is that a successful endo-
vascular procedure saves a very high percentage of limbs at
follow-up in a highly selected patient population with
ischaemic diabetic foot and isolated tibial, peroneal or
foot-artery disease; on the other hand, as observed by
other authors,17 the patients in whom re-vascularisation
failed had a very poor prognosis.
Bypass surgery using outflow vessels in the distal ankle
and foot should be considered the standard of care in
patients with CLI due to BTK-vessel disease.18 However, itFigure 4 KaplaneMeier survival curves (and 95% confidence
bands) for successful (group 1, solid line) and unsuccessful
(group 2, dashed line) PTA.needs a good vein conduit and at least one open foot artery
and is associated with 0.9% perioperative mortality, 3.0%
myocardial infarction or acute congestive heart failure and
6.6% early re-operation for graft thrombosis, postoperative
bleeding or infection.19 For these reasons, femoro-popliteal
and infrapopliteal PTA is currently proposed as the primary
treatment for CLI in patients with ischaemic diabetic
foot2,3,7e9 but, although many published papers have
described interesting findings concerning the efficacy of the
endovascular treatment of peripheral artery disease in such
patients, there are discrepancies between the short- and
long-term results because the studies have not involved
carefully selected patient populations or appropriately
stratified the vessels on the basis of the degree and local-
isation of atherosclerosis.
In particular, the use of PTA to treat BTK arteries is
criticised because of the small diameter and length of the
treated vessel e both of which tend to lead to a high re-
stenosis rate; furthermore, it is not clear whether the
clinical success of BTK-artery PTA is authentic or simply
the result of improved outflow due to concomitant ATK
procedures.20e23
In order to more precisely evaluate the clinical
outcomes of PTA in patients with isolated BTK-vessel
involvement, we excluded those with distal popliteal and
tibioperoneal trunk disease because the diameters of these
vessels are more similar to those of ATK arteries than those
of the other smaller BTK arteries. This meant that the
studied population consisted of a very homogeneous group
of predominantly male patients with widespread small BTK-
vessel involvement (66% had three diseased leg vessels and
43% two diseased foot vessels), a lesion length of >10 cm in
most cases and an extraordinary length of treated vessel
per procedure (up to 20 cm). However, despite the severity
of the disease, the successful endovascular procedures led
to optimal follow-up outcomes. Although this population
only represents a minority of the patients referred for CLI
treatment, they are technically challenging, and our results
support the role of PTA as the therapeutic option for CLI
patients with BTK-artery disease.
The limb salvage rate was 93% despite a US re-stenosis
rate of 42%. This discrepancy probably reflects the fact that
long-term complete patency of the treated vessel is less
important in such patients than in those with coronary,
carotid or renal arterial disease: the re-canalisation
temporarily increases blood flow to the foot and has
a positive effect in eradicating infection and healing ulcers
and surgical wounds. As foot tissue healing reduces oxygen
demand, less blood flow is generally required to maintain
tissue integrity and keep the limb asymptomatic.4,24 This is
clearly demonstrated by the fact that only three of our 94
patients who underwent a total of 100 successful PTA
procedures experienced recurrent CLI in the same limb
during the follow-up period.
The effectiveness of PTA was demonstrated by the
increase in TcPO2 values 1 month after the procedure. This
may explain the low rate of major amputations, as reported
by Faglia et al.,25 who looked specifically at the prognostic
value of this index.
Finally, the incidence of follow-up mortality was only
8%, definitely lower than the annual 20% death rate for
patients with CLI reported in the ‘TASC 2007’ document.26
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were younger, and the proportion with hypertension,
coronary artery disease or a history of stroke or haemo-
dialysis was lower than that observed in the patients
enrolled in other studies2e10; (2) they closely adhered to
our programme’s very strict clinical follow-up schedule and
(3) the exclusively BTK localisation of disease may identify
a population with less extensive systemic atherosclerosis
than patients with simultaneous ATK and BTK involvement.
It is important to note that the majority of follow-up deaths
occurred in those patients who had undergone unsuccessful
PTA and showed diffuse and heavy calcification of the limb
and foot arteries, a marker that has been previously iden-
tified as a strong predictor of a poor prognosis.27e29
Study limitations
This is a retrospective case review and no independent
angiographic or US core laboratories were involved; this
may have led to a potential evaluation bias.
Our high rate of limb salvage at follow-up may have been
due to our definition of ‘successful’ PTA because, as
recently reported by Faglia et al.,25 the restoration of
straight-line flow down to the foot in at least one crural
artery is of paramount importance for short- and long-term
clinical success. Another explanation may be the combi-
nation of PTA and a good surgical approach to foot lesions
(before and after the procedure), together with a strict
clinical follow-up.
Follow-up re-stenosis in the surviving limbs was only
ascertained by US. It is well known that angiography is the
gold standard for evaluating infrapopliteal arteries, but US
can be used to assess infrapopliteal artery patency if
appropriate criteria are adopted.3,30,31
Conclusions
In our study, pure isolated BTK-vessel disease seemed to
identify a patient population characterised by a younger
age and lower incidence of co-morbidities than those
observed in patients with concomitant ATK- and BTK-vessel
disease. In this selected population, successful angioplasty
led to a very high rate of limb salvage and good long-term
prognosis; although it must be borne in mind that complete
patency of the treated vessel at follow-up seems to be less
important than in other clinical situations. Further studies
are needed to confirm the results of this study.
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